Skip to main content

Anti-glomerular Basement Membrane Disease

  • Reference work entry
  • First Online:
Glomerulonephritis
  • 2060 Accesses

Abstract

Anti-GBM antibody disease is a rare autoimmune disorder characterized by circulating autoantibodies directed against specific antigenic targets within the glomerular and alveolar basement membranes. It is extremely uncommon in children, and typically presents with acute renal failure caused by a rapidly progressive glomerulonephritis that is commonly associated with crescentic changes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 599.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 899.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ang C, Savige J, Dawborn J et al (1998) Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function. Nephrol Dial Transplant 13(4):935–939

    Article  CAS  PubMed  Google Scholar 

  • Bailey RR, Simpson IJ, Lynn KL, Neale TJ, Doak PB, McGiven AR (1981) Goodpasture’s syndrome with normal renal function. Clin Nephrol 15(4):211–215

    CAS  PubMed  Google Scholar 

  • Bolton W (1984) The role of high dose steroids in nephritic syndromes: the case for aggressive use. In: Controversies in nephrology and hypertension. Churchill-Livingston, New York, p 421

    Google Scholar 

  • Bolton WK (1996) Goodpasture’s syndrome. Kidney Int 50(5):1753–1766

    Article  CAS  PubMed  Google Scholar 

  • Border WA, Baehler RW, Bhathena D, Glassock RJ (1979) IgA antibasement membrane nephritis with pulmonary hemorrhage. Ann Intern Med 91(1):21–25

    Article  CAS  PubMed  Google Scholar 

  • Couser WG (1988) Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 11(6):449–464

    Article  CAS  PubMed  Google Scholar 

  • Dean EG, Wilson GR, Li M et al (2005) Experimental autoimmune goodpasture’s disease: a pathogenetic role for both effector cells and antibody in injury. Kidney Int 67(2):566–575

    Article  CAS  PubMed  Google Scholar 

  • Donaghy M, Rees A (1983) Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 322(8364):1390–1393

    Article  Google Scholar 

  • Fervenza FC, Terreros D, Boutaud A et al (1999) Recurrent goodpasture’s disease due to a monoclonal IgA-kappa circulating antibody. Am J Kidney Dis 34(3):549–555

    Article  CAS  PubMed  Google Scholar 

  • Fox HL, Swann D (2001) Goodpasture syndrome: pathophysiology, diagnosis, and management. Nephrol Nurs J 28(3):305

    CAS  PubMed  Google Scholar 

  • Goodpasture EW (1919) The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci 158(6):863–870

    Article  Google Scholar 

  • Hellmark T, Burkhardt H, Wieslander J (1999) Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies. J Biol Chem 274(36):25862–25868

    Article  CAS  PubMed  Google Scholar 

  • Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport’s syndrome, goodpasture’s syndrome, and type IV collagen. N Engl J Med 348(25):2543–2556

    Article  CAS  PubMed  Google Scholar 

  • Johnansson C, Hellmark T, Wieslander J (1993) One major epitope in goodpasture’s syndrome. J Am Soc Nephrol 4:608

    Google Scholar 

  • Kalluri R, Meyers K, Mogyorosi A, Madaio MP, Neilson EG (1997) Goodpasture syndrome involving overlap with wegener’s granulomatosis and anti-glomerular basement membrane disease. J Am Soc Nephrol 8(11):1795–1800

    CAS  PubMed  Google Scholar 

  • Kefalides NA, Ohno N, Wilson CB (1993) Heterogeneity of antibodies in goodpasture syndrome reacting with type IV collagen. Kidney Int 43(1):85–93

    Article  CAS  PubMed  Google Scholar 

  • Lerner RA, Glassock RJ, Dixon FJ (1967) The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126(6):989–1004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Levy JB, Turner AN, Rees AJ, Pusey CD (2001) Long-term outcome of anti–glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134(11):1033–1042

    Article  CAS  PubMed  Google Scholar 

  • Matsukura H, Butkowski R, Fish A (1993) The goodpasture antigen: common epitopes in the globular domains of collagen IV. Nephron 64(4):532–539

    Article  CAS  PubMed  Google Scholar 

  • McLeish KR, Yum MN, Luft FC (1978) Rapidly progressive glomerulonephritis in adults: clinical and histologic correlations. Clin Nephrol 10(2):43–50

    CAS  PubMed  Google Scholar 

  • Merkel F, Pullig O, Marx M, Netzer KO, Weber M (1994) Course and prognosis of anti-basement membrane antibody (anti-BM-ab)-mediated disease: report of 35 cases. Nephrol Dial Transplant 9(4):372–376

    CAS  PubMed  Google Scholar 

  • Morrison KE, Mariyama M, Yang-Feng TL, Reeders ST (1991) Sequence and localization of a partial cDNA encoding the human alpha 3 chain of type IV collagen. Am J Hum Genet 49(3):545–554

    CAS  PubMed  PubMed Central  Google Scholar 

  • Netzer KO, Leinonen A, Boutaud A et al (1999) The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17–31 and 127–141 of the NC1 domain. J Biol Chem 274(16):11267–11274

    Article  CAS  PubMed  Google Scholar 

  • Pedchenko V, Bondar O, Fogo AB et al (2010) Molecular architecture of the goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 363(4):343–354

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Phelps RG, Rees AJ (1999) The HLA complex in goodpasture’s disease: a model for analyzing susceptibility to autoimmunity. Kidney Int 56(5):1638–1653

    Article  CAS  PubMed  Google Scholar 

  • Salama AD, Chaudhry AN, Ryan JJ et al (2001) In goodpasture’s disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1. J Am Soc Nephrol 12(9):1908–1915

    CAS  PubMed  Google Scholar 

  • Salama AD, Dougan T, Levy JB et al (2002) Goodpasture’s disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis 39(6):1162–1167

    Article  PubMed  Google Scholar 

  • Salama AD, Chaudhry AN, Holthaus KA et al (2003) Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in goodpasture’s (anti-GBM) disease. Kidney Int 64(5):1685–1694

    Article  CAS  PubMed  Google Scholar 

  • Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM (1986) Antiglomerular basement membrane antibody mediated disease in the british isles 1980-4. Br Med J (Clin Res Ed) 292(6516):301–304

    Article  CAS  PubMed Central  Google Scholar 

  • Shah MK, Hugghins SY (2002) Characteristics and outcomes of patients with goodpasture’s syndrome. South Med J 95(12):1411–1419

    Article  PubMed  Google Scholar 

  • Sinico RA, Radice A, Corace C, Sabadini E, Bollini B (2006) Anti-glomerular basement membrane antibodies in the diagnosis of goodpasture syndrome: a comparison of different assays. Nephrol Dial Transplant 21(2):397–401

    Article  CAS  PubMed  Google Scholar 

  • Syeda UA, Singer NG, Magrey M (2013) Anti-glomerular basement membrane antibody disease treated with rituximab: a case-based review. Semin Arthritis Rheum 42(6):567–572

    Article  PubMed  Google Scholar 

  • Turner N, Mason PJ, Brown R et al (1992) Molecular cloning of the human goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 89(2):592–601

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wilson CB, Dixon FJ (1973) Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 3(2):74–89

    Article  CAS  PubMed  Google Scholar 

  • Wu J, Hicks J, Ou C, Singleton D, Borillo J, Lou YH (2001) Glomerulonephritis induced by recombinant collagen IV alpha 3 chain noncollagen domain 1 is not associated with glomerular basement membrane antibody: a potential T cell-mediated mechanism. J Immunol 167(4):2388–2395

    Article  CAS  PubMed  Google Scholar 

  • Wu J, Hicks J, Borillo J, Glass WF 2nd, Lou YH (2002) CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 109(4):517–524

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zimmerman SW, Varanasi UR, Hoff B (1979) Goodpasture’s syndrome with normal renal function. Am J Med 66(1):163–171

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Corinne Benchimol .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Benchimol, C. (2019). Anti-glomerular Basement Membrane Disease. In: Trachtman, H., Herlitz, L., Lerma, E., Hogan, J. (eds) Glomerulonephritis. Springer, Cham. https://doi.org/10.1007/978-3-319-49379-4_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-49379-4_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-49378-7

  • Online ISBN: 978-3-319-49379-4

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics